Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application

W Chiangjong… - … journal of oncology, 2020 - spandidos-publications.com
Cancer is currently ineffectively treated using therapeutic drugs, and is also able to resist
drug action, resulting in increased side effects following drug treatment. A novel therapeutic …

Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases

E Kole, K Jadhav, N Shirsath, P Dudhe… - Journal of Drug Delivery …, 2023 - Elsevier
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

Antimicrobial peptides in early-life host defense, perinatal infections, and necrotizing enterocolitis—An update

E Agakidou, C Agakidis, A Kontou, W Chotas… - Journal of Clinical …, 2022 - mdpi.com
Host defense against early-life infections such as chorioamnionitis, neonatal sepsis, or
necrotizing enterocolitis (NEC) relies primarily on innate immunity, in which antimicrobial …

Taming the devil: antimicrobial peptides for safer TB therapeutics

K Jadhav, R Singh, E Ray, AK Singh… - Current Protein and …, 2022 - ingentaconnect.com
Tuberculosis (TB) is a highly contagious infection with extensive mortality and morbidity. The
rise of TB-superbugs (drug-resistant strains) with the increase of their resistance to …

Non‐canonical amino acid bioincorporation into antimicrobial peptides and its challenges

GN Enninful, R Kuppusamy, EK Tiburu… - Journal of Peptide …, 2024 - Wiley Online Library
The rise of antimicrobial resistance and multi‐drug resistant pathogens has necessitated
explorations for novel antibiotic agents as the discovery of conventional antibiotics is …